A melanoma-associated antigen. When administered in a vaccine formulation, gp100 antigen may stimulate a cytotoxic T cell HLA-A2.1-restricted immune response … [Read more...]
G
gp100-fowlpox vaccine
A cancer vaccine comprised of a recombinant fowlpox virus vector encoding the melanoma antigen glycoprotein 100 (gp 100) with potential antineoplastic activity. … [Read more...]
gp100:154-162 peptide vaccine
A peptide consisting of amino acid residues 154 through 162 of the melanoma-melanocyte antigen gp100. Vaccination with gp100:154-162 peptide may enhance … [Read more...]
gp100:209-217(210M) peptide vaccine
A synthetic peptide cancer vaccine consisting of amino acid residues 209 through 217 of the glycoprotein 100 (gp100) melanoma antigen, with a methionine … [Read more...]
gp100:280-288(288V) peptide vaccine
A peptide vaccine consisting of the amino acids 280 through 288 of the melanoma antigen glycoprotein 100 (gp100) with potential antineoplastic activity. … [Read more...]
gp209-2M
A peptide (short piece of protein) made from the tumor-specific antigen gp100, and used to make vaccines being studied in the treatment of melanoma. … [Read more...]
gp96 heat shock protein-peptide complex vaccine
A vaccine made from a patient … [Read more...]
gp96 HSP-peptide complex
A vaccine made from a patient … [Read more...]
gp96-Ig fusion protein-expressing non-small cell lung cancer cell vaccine
A cancer vaccine consisting of irradiated non-small cell lung cancer cells, manipulated to express and secrete heat shock protein gp96-Ig fusion protein, with … [Read more...]
GPI-0100
A semi-synthetic triterpene glycoside, derived from the naturally occurring saponins. GPI-0100 functions as an adjuvant when given as part of a vaccine … [Read more...]